Indegene Ltd

Miscellaneous

Offer Period :

6th to 5th May 2024

Indegene Ltd IPO Details

IPO Date 6th to 5th May 2024 Minimum Investment ₹14916 / 1 Lots
Listing Date 2024-05-13 Maximum Investment ₹193908 / 13 Lots
Face Value ₹2 per share Total Issue Size ₹1841.76 Crores
Price ₹452 to ₹452 per share Fresh Issue ₹760 Crores
Lot Size 1 Lots (33 Shares) Offer For Sale ₹ 1081.76
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹ 0    
IPO Date 6th to 5th May 2024
Listing Date 2024-05-13
Face Value ₹2 per share
Price ₹452 to ₹452 per share
Lot Size 1 Lots (33 Shares)
Listing At BSE, NSE
Employee Discount ₹0 Crores
Minimum Investment ₹14916 / 1 Lots
Maximum Investment ₹193908 / 13 Lots
Total Issue Size ₹1841.76 Crores
Fresh Issue ₹760 Crores
Offer For Sale
Retail Discount ₹ 0

Tentative Timeline

Important dates for allocation and IPO listing.

6th May

IPO Starts

8th May

IPO Ends

9th May

Allotment Date

10th May

Initiation of Refund

10th May

Credit of Shares to Demat Account

13th May

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 100 100

Indegene Ltd IPO Reservation

QIB Shares Offered 8094068(19.86%)
NII (HNI) Shares Offered 6070551(14.9%)
Retail Shares Offered 14164620(34.76%)
Anchor Investor Shares Offered 12141103(29.8%)
Total Shares Offered 40746892
Total Shares With Anchor Investor 40746892

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Indegene Ltd IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id indegene.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Indegene Ltd IPO Lead Manager

1. Kotak Mahindra Capital Company Ltd

2. Citigroup Global Markets India Pvt Ltd

3. J.P. Morgan India Pvt Ltd

4. Nomura Financial Advisory & Sec. (India) Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Indegene Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Indegene Ltd

1. Domain expertise in healthcare.

2. Robust digital capabilities and in-house developed technology portfolio.

3. Track record of establishing long-standing client relationships.

4. Global delivery model.

5. Experienced management and motivated talent pool supported by marquee investors.

6. Track record of creating value through acquisitions.

Risks Involved

1. Its business is solely focused on the life sciences industry and may be adversely impacted by factors affecting the life sciences industry, including the growth of the overall life sciences industry, outsourcing and other trends.

2. As its business is solely focused on the life sciences industry and a significant portion of its business is attributable to certain large clients located in North America and Europe, its business and profitability is dependent on factors affecting the life sciences industry and the company continuing relationships with such key clients.

3. Its business and revenue models may be unfamiliar to prospective investors.

4. The majority of its revenues are derived from the company Subsidiaries. Any disruptions in the operations of one or more of its Subsidiaries may adversely affect its business, financial condition, results of operations.

5. The company proposes to utilize approximately 52.41% of the Net Proceeds by way of investments in its Subsidiaries by way of debt, towards identified objects of the Offer. The use of such funds will be subject to the laws of the countries in which its Subsidiaries are incorporated, and the company may have limited control over the manner in which such funds are utilized.

6. The life sciences operations industry is highly competitive, and it is difficult to predict its future prospects.

7. Its business continuity and disaster recovery plans may be inadequate. If any disruption that the company has not contemplated in its business continuity and disaster recovery plans occurs or if the company is unable to ensure that key services are resumed within agreed timelines, its business, financial condition and results of operations may be adversely affected.

8. There may be delays in timing of revenue recognition which may cause its margins to fluctuate.

9. If the company is unable to manage attrition and attract and retain skilled professionals, it may have an adverse impact on its business prospects, reputation and future financial performance.

10. If the company underprice its work orders, overrun its cost estimates, or fail to receive approval for or experience delays in documentation of change orders, its business, financial condition, results of operations, or cash flows may be adversely affected.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2023 2022 2021
Total Assets 2203.87 1353.47 596.04
Total Liabilities 2203.87 1353.47 596.04
Total Expenses 2001.05 1417.1 768.25
Total Revenue 
2364.1 1690.5 996.92
Profit After Tax 266.1 164.76 149.4
EBITDA 454.19 265.91 263.96
Adjusted EBITDA 0 0 0

Indegene Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-05-13 544172 INDGN
INE065X01017
₹452 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹452 ₹452
Open ₹659.7 ₹655
Low ₹527.8 ₹527.1
High ₹659.7 ₹660
Low ₹527.8 ₹527.1

Frequently Asked Questions

What is Indegene Ltd IPO?

Answer Field

Indegene Ltd IPO is a Mainboard IPO of 4,07,46,892 equity shares of a face value of ₹2 aggregating up to ₹1841.76 Crores. The issue is priced at ₹452 to ₹452 per share. The minimum order quantity is 33 Shares. The IPO opens on May 06, 2024, and closes on May 08, 2024. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Indegene Ltd IPO will open?

Answer Field

The Indegene Ltd IPO opens on May 06, 2024 and closes on May 08, 2024.

What is the lot size of Indegene Ltd?

Answer Field

Indegene Ltd lot size is 33 shares, and the minimum amount required is ₹14,916.

How to apply for Indegene Ltd IPO?

Answer Field

You can apply in Indegene Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Indegene Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Indegene Ltd IPO will be done on May 09, 2024, and the allotted shares will be credited to your demat account by May 10, 2024.

When is Indegene Ltd IPO listing date?

Answer Field

The Indegene Ltd listing date is May 13, 2024.

Who is the registrar of Indegene Ltd IPO?

Answer Field

The registrar of Indegene Ltd IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Ltd,Citigroup Global Markets India Pvt Ltd,J.P. Morgan India Pvt Ltd,Nomura Financial Advisory & Sec. (India) Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Indegene Ltd IPO?

Answer Field

The fresh issue size is ₹760 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Indegene Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 33 shares and ₹14,916 amount.

How can I approve the UPI mandate request for Indegene Ltd IPO?

Answer Field

To apply for Indegene Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Indegene Ltd?

Answer Field

The price of each Indegene Ltd share will be ranging in between ₹452 to ₹452 per share.

What is the cut-off time for the UPI mandate for Indegene Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, May 08, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • TBO TEK LIMITEDMainboard IPO

  • Bidding Dates

    8th May 2024 - 5th May 2024

  • Price Range

    ₹875 - 920

  • IPO Size

    ₹15,50,81,00,000

  • Invest Now
  • INDEGENE LIMITEDMainboard IPO

  • Bidding Dates

    6th May 2024 - 5th May 2024

  • Price Range

    ₹430 - 452

  • IPO Size

    ₹18,41,76,00,000

  • Invest Now

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text